PPA
SCPH

Parametric Portfolio Associates’s scPharmaceuticals SCPH Stock Holding History

Parametric Portfolio Associates’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,268
Closed -$60K – 3994
2019
Q3 		$60K Sell
10,268
-1,276
-11% -$7.2K ﹤0.01% 3891
2019
Q2 		$37K Sell
11,544
-6,781
-37% -$22.2K ﹤0.01% 3929
2019
Q1 		$55K Sell
18,325
-21,449
-54% -$73.7K ﹤0.01% 3884
2018
Q4 		$150K Buy
39,774
+6,421
+19% +$30.2K ﹤0.01% 3721
2018
Q3 		$196K Buy
+33,353
New +$170K ﹤0.01% 3768

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return

Parametric Portfolio Associates's SCPH Position: Q4 2019 in Review

Parametric Portfolio Associates sold out of scPharmaceuticals (SCPH) in Q4 2019, closing a stake of 10,268 shares — an estimated $60K sold.

Parametric Portfolio Associates first reported a position in SCPH in Q3 2018 and held it in 5 quarters. The position peaked at $196K in Q3 2018. 27 funds tracked by Wall St. Rank hold SCPH as of Q4 2019.

  • Parametric Portfolio Associates reported no remaining scPharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 10,268 scPharmaceuticals shares in Q4 2019, an estimated $60K.
  • Parametric Portfolio Associates first reported a position in scPharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Parametric Portfolio Associates's scPharmaceuticals position peaked at $196K in Q3 2018.
  • 27 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2019.

Based on Parametric Portfolio Associates's 13F filing for Q4 2019, filed 14 Feb 2020.